Faculty Opinions recommendation of Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.

Myelogenous Leukemia ◽

Hematopoietic Stem ◽

Acute Myelogenous ◽

Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of High-Risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome Using Reduced-Intensity Conditioning with Fludarabine and Melphalan

10.1016/j.bbmt.2006.11.024 ◽

2007 ◽

Vol 13 (4) ◽

pp. 454-462 ◽

Cited By ~ 93

Author(s):

Betul Oran ◽

Sergio Giralt ◽

Rima Saliba ◽

Chitra Hosing ◽

Uday Popat ◽

...

Keyword(s):

Stem Cell ◽

High Risk ◽

Myelogenous Leukemia ◽

Hematopoietic Stem ◽

Acute Myelogenous ◽

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia

Current Opinion in Oncology ◽

10.1097/cco.0b013e3282f0e188 ◽

2007 ◽

Vol 19 (6) ◽

pp. 660-666 ◽

Cited By ~ 14

Author(s):

David Valcárcel ◽

Rodrigo Martino

Keyword(s):

Stem Cell ◽

Myelodysplastic Syndromes ◽

Myelogenous Leukemia ◽

Hematopoietic Stem ◽

Acute Myelogenous ◽

Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome

Supportive Care in Cancer ◽

10.1007/s00520-009-0779-z ◽

2009 ◽

Vol 18 (12) ◽

pp. 1565-1569 ◽

Cited By ~ 5

Author(s):

Osamu Imataki ◽

Takeshi Kamioka ◽

Takashi Fukuda ◽

Ryuji Tanosaki ◽

Yoichi Takaue

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Myelogenous Leukemia ◽

Hematopoietic Stem ◽

Acute Myelogenous ◽

Long-Term Outcomes of Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Secondary to Myelodysplastic Syndrome

10.1016/j.bbmt.2013.10.021 ◽

2014 ◽

Vol 20 (1) ◽

pp. 111-117 ◽

Cited By ~ 19

Author(s):

Victoria T. Potter ◽

Pramila Krishnamurthy ◽

Linda D. Barber ◽

ZiYi Lim ◽

Michelle Kenyon ◽

...

Keyword(s):

Stem Cell ◽

Myelogenous Leukemia ◽

Long Term Outcomes ◽

Hematopoietic Stem ◽

Acute Myelogenous ◽

Hematopoietic Stem Cell Transplantation after Reduced Intensity Conditioning in Acute Myelogenous Leukemia Patients Older Than 40 Years

10.1016/j.bbmt.2007.09.017 ◽

2008 ◽

Vol 14 (2) ◽

pp. 181-186 ◽

Cited By ~ 12

Author(s):

Cynthia Huisman ◽

Ellen Meijer ◽

Eefke J. Petersen ◽

Henk M. Lokhorst ◽

Leo F. Verdonck

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Myelogenous Leukemia ◽

Hematopoietic Stem ◽

Acute Myelogenous ◽

Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Patients with Treatment-Related Myelodysplastic Syndrome or Acute Myelogenous Leukemia

10.1016/j.bbmt.2011.11.009 ◽

2012 ◽

Vol 18 (3) ◽

pp. 473-480 ◽

Cited By ~ 12

Author(s):

Rachel Kobos ◽

Peter G. Steinherz ◽

Nancy A. Kernan ◽

Susan E. Prockop ◽

Andromachi Scaradavou ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Pediatric Patients ◽

Myelogenous Leukemia ◽

Hematopoietic Stem ◽

Acute Myelogenous

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome

Cancer ◽

10.1002/cncr.25500 ◽

2010 ◽

Vol 116 (23) ◽

pp. 5420-5431 ◽

Cited By ~ 284

Author(s):

Marcos de Lima ◽

Sergio Giralt ◽

Peter F. Thall ◽

Leandro de Padua Silva ◽

Roy B. Jones ◽

...

Keyword(s):

Stem Cell ◽

Maintenance Therapy ◽

Low Dose ◽

Myelogenous Leukemia ◽

Hematopoietic Stem ◽

Acute Myelogenous

Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation

10.1016/j.bbmt.2016.12.160 ◽

2017 ◽

Vol 23 (3) ◽

pp. S263

Author(s):

Kristen Beyer ◽

Anthony J. Proli ◽

Junting Zheng ◽

Valkal Bhatt ◽

Andrew Lin ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Conditioning Regimen ◽

Myelogenous Leukemia ◽

Hematopoietic Stem ◽

Acute Myelogenous

Hematopoietic Stem Cell Transplantation in Children and Young Adults with Secondary Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Aplastic Anemia

10.1016/j.bbmt.2013.11.031 ◽

2014 ◽

Vol 20 (3) ◽

pp. 425-429 ◽

Cited By ~ 9

Author(s):

Ayami Yoshimi ◽

Brigitte Strahm ◽

Irith Baumann ◽

Ingrid Furlan ◽

Stephan Schwarz ◽

...

Keyword(s):

Young Adults ◽

Stem Cell ◽

Myelogenous Leukemia ◽

Hematopoietic Stem ◽

Secondary Myelodysplastic Syndrome ◽

Acute Myelogenous ◽

Children And Young Adults

TBI-Based Reduced Intensity Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation (SCT) in Patients with High-Risk Hematologic Malignancies

Transplantation in Hematology and Oncology II ◽

10.1007/978-3-642-55774-3_11 ◽

2003 ◽

pp. 91-94

Author(s):

M. J. Kröger ◽

A. Schuck ◽

M. Kiehl ◽

G. Silling ◽

R. Leo ◽

...

Keyword(s):

Stem Cell ◽

High Risk ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematologic Malignancies ◽

Hematopoietic Stem ◽